All posts by student

Revealing New Details of Cancer Biology with Automated Kinetic Live Cell Imaging – Bioscience Technology

Decades of research into characterization, prevention, detection and treatment have substantially expanded our collective understanding of cancer biology. However, these insights elicit a new generation of unanswered questions about the complexity of this group of often-deadly diseases. Historical investigations yielded the key understandings that cancer cells arise from indigenous cells, and most, if not all, tumors are derived from a single parent cell1. In 2000, Hanahan and Weinberg simplified the many aspects of transformation from normal human cells into cancerous ones through six essential cell physiology alterations. These so-called hallmarks of cancer include self-sufficiency in growth signals, insensitivity to anti-growth or inhibitory signals, evasion of apoptosis, unlimited replication capability, sustained angiogenesis, and tissue invasion and metastasis2. They later added deregulating cellular energetics and avoiding immune destruction as emerging hallmarks; genome instability and mutation and tumor-promoting inflammation as enabling characteristics3. The impact of external stimuli, interactions with neighboring cells and the extracellular matrix (ECM), heterogeneity, inherited traits, and other factors further complicate the elucidation of cancer biology.

Along with the expanding scope of research interests, methodologies have evolved to include live cell studies in addition to conventional biochemical and fixed cell assays. Live cell assays allow researchers to dynamically study a cells function in an environment that better represents in vivo conditions. Kinetic imaging of live cells provides a useful framework in which to gather meaningful details of cellular dynamics in real time, however, applications are often constrained by the limited versatility of available instruments. Most imaging systems are not suitable for capturing the widely ranging timelines in which cellular events occur from sub-second responses to events manifesting over days or weeks. Thus, multiple, dedicated instruments or bulky external accessories are often required, taking up precious bench space. Similarly, integrated image processing and data analysis is frequently limited or requires additional software to properly quantify the captured information.

Here, we describe an automated live cell imager designed for a wide range of temporal dynamics in live cell assays. Specifically, we demonstrate its capabilities for short-, medium- and long-term kinetic assays typically used when investigating cancer hallmarks. The integrated design of this system precludes the use of multiple instruments, while the advanced image capture and data analysis features deliver powerful and actionable insights.

Dysregulation of cellular signaling is a significant foundation for most of the aforementioned hallmarks of cancer4. Capturing a rapid, short-lived signaling event, such as calcium flux following GPCR activation, requires high temporal resolution. The automated live cell imager provides image capture rates of up to 20 frames per second, while in-line injectors enable reagent addition with continuous monitoring of cellular response. In the provided calcium mobilization example, we characterize the ATP-induced activation of endogenously expressed P2Y receptors in HeLa cells, using the cell membrane permeable calcium indicator dye Fluo-4 AM. Binding of calcium ions to Fluo-4 causes a structural change that results in a significant increase in fluorescence quantum yield and more than a hundred-fold increase in fluorescence relative to the unbound state. Per Figure 1, ATP (10 M final) was injected at t=5 seconds, an increase in intracellular calcium was detected approximately 3 seconds after the addition, and peak calcium mobilization for the entire field of cells was reached 13 seconds post-ATP addition. Image preprocessing and object masking tools reduced background fluorescence and a generated a larger assay window compared to total fluorescence measurements, resulting in a seven-fold increase in relative Fluo-4 fluorescence following ATP addition.

The relationship between wound healing and tumorigenesis is well-established5,6. Additionally, although migration is a function of normal cells, it is considered one of the hallmarks of cancer when dysregulated signals lead to cancer metastasis. Scratch assays are widely used to investigate in vitro cell migration and wound healing, where a monolayer cell culture is manually scratched to generate an area free of cells into which surrounding cells can migrate and proliferate. The imaging chamber of the automated live cell imager maintains cell health through consistent environmental conditions, including temperature, gas and humidity levels, over the entire incubation period, which is cell-dependent, but typically lasts no more than twenty-four hours. Automated phase contrast (label-free) imaging tracks the migratory characteristics of the cell model at pre-determined time points, while advanced software automatically places object masks to track parameters such as object size, area and total signal over the incubation period. In the provided scratch assay example, an approximately 500 m wide wound was created using HT-1080 fibrosarcoma cells and ibidi culture inserts. Per Figure 2A, the wound was treated with different concentrations of the migration inhibitor, cytochalasin D; and kinetic images were captured over twenty-four hours, while the cells were incubated under controlled conditions of 37 C, 5 percent CO2. Percent confluency was calculated (Figure 2B), showing that wound closure inhibition is proportional to cytochalasin D concentration, to the point where cytotoxicity begins to affect the cells neighboring the wound.

View original post here:
Revealing New Details of Cancer Biology with Automated Kinetic Live Cell Imaging - Bioscience Technology

Sandra Oh Just Landed Her Best Role Since Grey’s Anatomy – Cinema Blend

Sandra Oh will play Eve in the eight-episode first season of Killing Eve, which will air on BBC America. The role promises to give Oh the chance to stretch her dramatic and comedic muscles. Killing Eve is actually based on novellas penned by writer Luke Jennings, so it should be interesting to see how the plots and characters of the series compare with the source material. The project will be helmed by Phoebe Waller-Bridge, who is best known for creating, writing, and starring in the acclaimed comedy Fleabag. She'll work as showrunner and executive producer on Killing Eve.

See the rest here:
Sandra Oh Just Landed Her Best Role Since Grey's Anatomy - Cinema Blend

OSU baseball: The anatomy of the Beavers’ extraordinary win streaks – Albany Democrat Herald

The two longest winning streaks in Division I baseball this year belong to Oregon State.

The top-seeded Beavers (54-4), who open the College World Series at noon Saturday against Cal State Fullerton (39-22), will take the field at TD Ameritrade Park in Omaha, Nebraska as winners of 21 consecutive games. OSU closed the regular season with 16 straight victories and has outscored opponents 44-9 during its five NCAA tournament games.

Earlier this year, the Beavers won a program-record 23 in a row from Feb. 25 to April 9, including a 12-0 start in Pac-12 play.

The two streaks have accounted for 44 of the teams 54 victories, another single-season school record. With a winning percentage of .931, OSU is on pace to break Arizona States 45-year-old all-time mark of .914 (the Sun Devils finished 64-6 in 1972).

Below is a breakdown of the Beavers winning streaks.

Runs scored: 136 (5.9 per game)

Runs allowed: 49 (2.1 per game)

A loss to Ohio State, which finished 148th in the NCAA RPI, dropped Oregon State to 5-1 early in the season.

The Beavers began the longest winning streak in school history with a 5-2 neutral-site victory over Nebraska, which later came to Oregon for the Corvallis Regional. OSU then got revenge against the Buckeyes to wrap up play in Surprise, Arizona before sweeping consecutive home series with UC Davis and Ball State.

Entering Pac-12 play 14-1 overall, the Beavers outscored Arizona State 16-1 during the three-game set to seize an immediate stranglehold on the conference standings. Starting pitchers Luke Heimlich (eight two-hit innings), Bryce Fehmel (eight innings, one run, four hits) and Jake Thompson (7 two-hit innings) were close to untouchable in the desert.

OSU picked up its first of six walk-off wins at Goss Stadium on March 24, knocking off Arizona 4-3 on a KJ Harrison single that plated Adley Rutschman. The Beavers trailed 3-1 entering the eighth.

One night later, OSU again overcame a deficit and walked off again when Preston Jones scored all the way from second on a wild pitch for a 5-4 win. A comfortable 11-7 decision in the series finale pushed the team to 20-1 overall and 6-0 in Pac-12 play.

The Beavers kept the streak alive with another come-from-behind effort, scoring three times in the ninth to steal a 4-3 victory at Saint Marys on March 28. Nick Madrigal collected the game-winning hit, a two-out, two-RBI single with the bases loaded.

Following another road sweep in which the Beavers outscored Stanford 25-8, OSU pulled out a 4-3 road decision at Portland for its 20th win in a row. Rutschmans two-run single in the sixth put the Beavers in front for good.

A home sweep of Utah including two more walk-offs left OSU 28-1 overall (12-0 Pac-12). Steven Kwan hit a game-winning single in the opener while a Rutschman sacrifice fly brought home Jack Anderson for a 5-4, 16-inning victory in Game 2.

The streak finally came to an end April 13, a 3-2 loss at Washington. But the Beavers fought back to win the final two games of the series.

Runs scored: 158 (7.5 per game)

Runs allowed: 41 (2.0 per game)

After starting the year 28-1, the Beavers went just 5-3 during a two-week span from April 13-29. The rocky patch included a 7-5, 10-inning home loss to USC, which finished in the Pac-12 basement with Arizona State.

Oregon State came back to rout the Trojans 10-1 in the series finale, igniting a winning streak that has yet to end.

A midweek home victory over Oregon followed by a three-game sweep of California put the Beavers on the brink of the Pac-12 championship. After cruising past the Ducks in Game 1 of the Civil War conference series, Mitchell Verburg struck out Ryne Nelson with the bases loaded in the bottom of the ninth to seal a 5-4 victory and the outright Pac-12 title.

Verburgs heroics also delivered career win No. 1,000 for coach Pat Casey.

The Beavers blanked Oregon 1-0 to sweep the series and cruised by Portland two days later before coming out flat against Washington State May 19. Trailing 3-2 entering the ninth, Steven Kwan and Jack Anderson drew consecutive base-loaded walks off Cougars closer Scott Sunitsch for a true walk-off.

OSU went on to outscore Washington State 19-3 in the final two games of the series, finishing with the best record in conference history at 27-3.

The streak nearly ended again May 26 against Abilene Christian, the Beavers final regular-season opponent. Knotted at 4 in the bottom of the 11th, Anderson knocked in Andy Atwood with a single for the teams sixth walk-off of the year. Reliever Mitch Hickey proposed to his girlfriend on the Goss Stadium turf immediately following the game.

The Beavers entered the NCAA tournament with a 49-4 record and breezed through the Corvallis Regional, outscoring Holy Cross and Yale by a combined margin of 27-3. Two comfortable wins over Vanderbilt in the Corvallis Super Regional pushed the winning streak to 21 as OSU prepares for its CWS opener.

Continue reading here:
OSU baseball: The anatomy of the Beavers' extraordinary win streaks - Albany Democrat Herald

E3 2017: Grey’s Anatomy Star Jesse Williams Joins Detroit: Become Human – IGN

Share.

Quantic Dream's upcoming neo-noir adventure, Detroit: Become Human, has a new cast member: Grey's Anatomy star Jesse Williams.

The actor plays a character named Marcus, and he was unveiled in a new gameplay demo on-stage, which saw him leading a group of androids in revolt against Detroit's humans.

Williams confirmed the news on Twitter, where he retweeted several mentions of the latest footage and simply said "It goes down in Detroit." Developer Quantic Dream confirmed on Twitter that Marcus is the third playable character in Detroit, joining previously-revealed characters Kara and Connor.

Detroit: Become Human was announced during Sony's Paris Games Week keynote in 2015. Based on Quantic Dream's "Kara" tech demo from 2012, Detroit: Become Human follows a number of playable characters in a world of sentient androids.

The story of Detroit: Become Human, similar to Heavy Rain, will feature several branching paths depending on player choices and character deaths. For more on the games of E3 2017, stay tuned to our E3 event hub.

Chloi Rad is an Associate Editor for IGN. Follow her on Twitter at @_chloi.

Read more:
E3 2017: Grey's Anatomy Star Jesse Williams Joins Detroit: Become Human - IGN

TV Guy: Adding razzle-dazzle to neuroscience – recordonline.com – Times Herald-Record

Kal Penn returns to host a second season of "Superhuman" (9 p.m., Fox, TV-PG).

Though the title may make some think of incredible feats of strength, the game show-like spectacle showcases people with remarkable gifts.

While most talent shows feature singers and dancers who have practiced on their abilities for years, the folks on "Superhuman" appear to have brains and bodies that have been wired a little differently, giving them unique skills that few of us could ever possess.

This season opener features a woman who perceives sounds and, more particularly, musical notes, as color. You have to see it!

A goofy guy from Brooklyn has the uncanny ability to tell the differences in nearly identical objects, allowing him to find the one brush stroke (out of 10,000 or so) that distinguishes one Monet reproduction from another.

There's a gymnast with a terrifyingly precise muscle memory and a man who can identify the sounds of thousands of species of frogs.

And there's also someone with a case of run-of-the-mill photographic memory.

It seems odd to call these folks "contestants." While they are vying for a $50,000 prize, you can't really call this a competition.

They have to appeal to Penn and celebrity judges Mike Tyson and Christina Milian to move forward.

Camera-ready neuroscientist Dr. Rahul Jandial is also on hand to explain how the players' brains and bodies allow them to perform their peculiar "acts."

Despite the presence of this scientific expert, "Superhuman" has the feel of a Las Vegas show.

There's even an appearance by the Blue Man Group in the first episode. Did I mention Mike Tyson?

Since there's really no objective way to determine a "winner," the prize in tonight's episode goes to the most "entertaining" ability. Even I could see that coming a mile away.

- Showtime dedicates four nights to "The Putin Interviews" (9 p.m., Showtime, TV-PG), a series of sit-downs between Russian leader Vladimir Putin and filmmaker Oliver Stone.

The event will reflect more than a dozen conversations conducted over a two-year period. The most recent took place in February.

As Megyn Kelly's recent interview showed us, speaking with Putin may be a casting coup, but it does not necessarily make for compelling television.

For starters, the presence of translators stifles the flow of conversation. Secondly, Putin is a poker-faced former spymaster whose emotions seem to run the gamut from chilly disdain to contemptuous anger.

Showtime has compared this to the David Frost-Richard Nixon conversations from 1977, but compared to Putin, Nixon now seems like Mr. Warmth.

Tonight's other highlights

- "American Ninja Warrior" (8 p.m., NBC, TV-PG) enters its ninth season in Los Angeles.

- Cat Deeley, Nigel Lythgoe and Mary Murphy return for the 14th season of "So You Think You Can Dance" (8 p.m., Fox, TV-14). Vanessa Hudgens joins as a guest judge.

- If required, the Cleveland Cavaliers and Golden State Warriors will meet in Game 5 of the NBA Finals (9 p.m., ABC).

- Trouble over Ireland on "Scorpion" (10 p.m., CBS, r, TV-14).

- Apolo Ohno and Kelvin Washington host "Spartan: Ultimate Team Challenge" (10 p.m., NBC, TV-PG), entering its second season.

- During a reunion with a pal, Jimmy resumes old ways on "Better Call Saul" (10 p.m., AMC, TV-14).

Series notes

Problems solved on "Kevin Can Wait" (8 p.m., CBS, r, TV-PG) ... The president (Lynda Carter) visits town on "Supergirl" (8 p.m., CW, r, TV-14) ... Thanksgiving plans unravel on "Man With a Plan" (8:30 p.m., CBS, r, TV-PG) ... Cold comfort on "Mom" (9 p.m., CBS, r, TV-14) ... On two episodes of "Whose Line Is It Anyway?" (CW, TV-14), Candace Patton (9 p.m.), Brett Dier (9:30 p.m., r) ... Reality bites on "Life in Pieces" (9:30 p.m., CBS, r, TV-14).

Late night

Roxane Gay is booked on "The Daily Show With Trevor Noah" (11 p.m., Comedy Central) ... Will Arnett, Rory Scovel and Luis Fonsi appear on "Conan" (11 p.m., TBS) ... Jimmy Fallon welcomes Demi Moore, Demetrius Shipp Jr., Nathaniel Rateliff, Charles Berry Jr. and Charles Berry III on "The Tonight Show" (11:35 p.m., NBC) ... Elisabeth Moss, John Mulaney, Brett Eldredge and Eric Moore visit "Late Night With Seth Meyers" (12:35 a.m., NBC) ... Salma Hayek and Sofia Coppola appear on "The Late Late Show With James Corden" (12:35 a.m., CBS).

kevin.tvguy@gmail.com

Visit link:
TV Guy: Adding razzle-dazzle to neuroscience - recordonline.com - Times Herald-Record

Neuroscience, Oncology Leaders Gather to Advance Brain Tumor Research at Feinstein Institute’s Brain Tumor Biotech … – PR Newswire (press release)

Brain tumors and CNS diseases can be very difficult to treat as most chemotherapy drugs cannot penetrate the blood-brain barrier, a natural defense mechanism that prevents substances in the bloodstream from getting into the brain. In addition, depending on the location of the tumor, surgery may not be possible. The 2017 Brain Tumor Biotech Summit examined some of the latest therapies aimed at conquering these challenges, including immunomodulatory therapies for glioblastoma multiforme (GBM), which uses the body's immune system to attack cancer cells, novel technologies to overcome the blood brain barrier to administer essential medications, and other innovative treatments for malignant glioma.

"Events like the Brain Tumor Biotech Summit inform medical professionals about new therapies on the horizon or currently being tested in the clinic, while also making those essential connections to spark new ideas and accelerate the development of novel therapies," said Marc Symons, PhD, co-director of the Feinstein Institute's Brain Tumor Biotech Center.

Along with discussing the latest therapies, attendees of the summit were given advice on best practices to maintain funding for research, and to start up and maintain a biotech company in the neuro-oncology space. This included a fireside chat with CNBC anchor Andrew Sorkin and a venture capital/investor panel led by biotech leader Franklin Berger.

About the Feinstein InstituteThe Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the Feinstein includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org

Contact:Heather E. Ball 516-465-7917 hball@northwell.edu

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neuroscience-oncology-leaders-gather-to-advance-brain-tumor-research-at-feinstein-institutes-brain-tumor-biotech-summit-300471807.html

SOURCE Feinstein Institute for Medical Research

http://www.feinsteininstitute.org/

Here is the original post:
Neuroscience, Oncology Leaders Gather to Advance Brain Tumor Research at Feinstein Institute's Brain Tumor Biotech ... - PR Newswire (press release)

Human nature Is crippling cyber security – ITProPortal

WannaCry, the recent devastating global ransomware attack, is now the largest of its kind in internet history. The attack has breached hundreds of thousands of computers in more than 150 countries, crippling a wide range of enterprises, from hospitals and universities to banks and warehouses.

In order to breach an enterprise, WannaCry and other forms of crypto-malware have been delivered in zip files, documents, or executables from the web, email attachments and on USB keys. Once WannaCry has infiltrated an organization, it moves laterally, holding computer networks hostage until a ransom is paid. I explained exactly how this process unfolded in a recent blog post:

The WannaCry crypto-malware variant uses the EternalBlue vector to move laterally in an organization. EternalBlue exploits a vulnerability in Microsofts implementation of the Server Message Block (SMB) protocol. This vulnerability is denoted by entry CVE-2017-0144. The vulnerability exists because the SMB version 1 (SMBv1) server in various versions of Windows accepts specially crafted packets from remote attackers, allowing them to execute arbitrary code on the target. To attack a target, the attacker must be able to reach it crossing the firewall. If a compromised computer has mounted shares or knows how to reach an SMB server, the attacker can use this to propagate from the compromised device to the SMB server.

While the attack is now largely in the rearview mirror, ransomware is still very much a concern among enterprises. WannaCry has created a number of lessons in its wake, and its important we take them into account in order to prevent an attack of this scale from happening again.

The first lesson is that quickly patching vulnerable systems is fundamental to stopping lateral spread in any organization. Next is that WannaCry, which was made possible by a leak of the NSAs hacking tools, served as the latest reminder that the good guys cannot keep vulnerabilities from falling into the wrong hands. But the most important takeaway is that humans will continue to cripple cyber security so long as it continues to play such a prominent role in protecting the enterprise.

Although Microsoft publicly released a patch addressing this specific vulnerability weeks before, the thousands of personal computers displaying the now-infamous red ransom script illustrated few had implemented it as instructed. (Of course, its not just humans that are to blame its the security paradigm. Windows XP users did not have this option since XP has been unsupported for three years.)

As I said in my commentary on the attack, As long as the industry continues to play this neverending cat and mouse game of patchwork systems, sophisticated attackers will easily find ways to exploit the public in increasingly large scale attacks such as this.

At Bromium, we released an industry study just a week before the WannaCry attack that underscored the point that humans continue to be the biggest threat to cyber security. We surveyed security professionals at the premier cyber security event, RSA Conference, as well as sec pros from the U.K. and U.S., and were shocked to find its not just unsuspecting end users we need to worry about, but those tasked to oversee the security operation.

We found that on average, 10 percent of security professionals admitted to paying a ransom or hiding a breach without alerting their team. This means that for every 10 individuals on your team, its likely that one of them has committed this act of subterfuge. (Someone might have even done it for WannaCry.) Keep in mind, these are only respondents who were willing to be forthcoming about their behavior if every security professional came forth about their behavior, I would expect this to be an even more alarming statistic.

There are several reasons why these undisclosed dealings are taking place on such a considerable scale. One is that ransoms typically arent that expensive. While paying $300 takes a cut of your checkbook, it is a small price to pay to maintain your professional reputation.

This leads into the main reason why professionals are hiding breaches: Getting owned is embarrassing. No one wants to face ridicule from co-workers or be reprimanded by their boss. But keeping these secrets from employers puts the enterprise at tremendous risk. Not only have you let someone into the network, but youve left a backdoor for the next breach, which is likely to be more complex. This finding not only speaks to the growing sophistication of cyber attacks, which are fooling those being paid handsomely to prevent them, but also to how we continue to underestimate the role humans play in cyber security.

he study also uncovered another deeply troubling finding: On average, 35 percent of security professionals admitted to bypassing their corporate security settings. No one is surprised when employees avoid security settings (at this point, its a given), but it is disturbing to see irresponsible decisions being made within the security department. When you cant trust whats happening on the front lines, it means the model is broken.

If there is one thing we should take away from the fallout of WannaCry, its that we are overdue for a reset in this industry. There is greater urgency than ever to map trustworthiness into technology, not humans. Cyber security solutions should eliminate human error, not enable it.

Enterprises need to embrace security that takes the burden off the end-user and ensures IT and security teams protect their business assets and data. Of course the positive corollary to doing that is end users go back to getting their work done without constraints placed on them by the security team.

While the potential losses from WannaCry are staggering, my hope is it will be a net positive for the industry that inspires sweeping changes across the board. Human nature is a variable that cannot be controlled, and as this episode demonstrated, it will continue to wreak havoc left unfettered. This attack should serve as a watershed moment that resets the security paradigm and actually embraces human behavior rather than try to change it.

Simon Crosby, co-founder and CTO of Bromium

Image Credit: WK1003Mike / Shutterstock

More:
Human nature Is crippling cyber security - ITProPortal

Scientists Discover First Genes for Insomnia – Sci-News.com

Researchers from Vrije Universiteit Amsterdam and elsewhere have identified seven risk genes for insomnia.

Insomnia is one of the most common health problems. Image credit: Dan Fa.

Insomnia is among the most frequent complaints in general practice. Even after treatment, poor sleep remains a persistent vulnerability for many people.

A research team led by Vrije Universiteit Professor Danielle Posthuma has come closer to unraveling the biological mechanisms that cause the predisposition for insomnia.

Our findings are the start of a path towards an understanding of insomnia at the level of communication within and between neurons, and thus towards finding new ways of treatment, Vrije Universiteit Professor Van Someren, co-author of the study.

As compared to the severity, prevalence and risks of insomnia, only few studies targeted its causes. Insomnia is all too often dismissed as being all in your head. Our research brings a new perspective. Insomnia is also in the genes.

To identify genetic factors for insomnia complaints, Prof. Posthuma, Prof. Someren and their colleagues performed a genome-wide association study and a genome-wide gene-based association study in 113,006 individuals.

As a result, the researchers identified seven genes associated with insomnia.

These genes play a role in the regulation of transcription, the process where DNA is read in order to make an RNA copy of it, and exocytosis, the release of molecules by cells in order to communicate with their environment, the authors said.

One of the identified genes, MEIS1, has previously been related to two other sleep disorders: periodic limb movements of sleep (PLMS) and restless legs syndrome (RLS).

Variants in the MEIS1 gene seem to contribute to all three disorders, they added.

Strikingly, PLMS and RLS are characterized by restless movement and sensation, respectively, whereas insomnia is characterized mainly by a restless stream of consciousness.

The team also found a strong genetic overlap with other traits, such as anxiety disorders, depression and neuroticism, and low subjective wellbeing.

This is an interesting finding, because these characteristics tend to go hand in hand with insomnia, said study first author Anke Hammerschlag, a PhD student at Vrije Universiteit.

We now know that this is partly due to the shared genetic basis.

The researchers also studied whether the same genetic variants were important for men and women.

Part of the genetic variants turned out to be different. This suggests that, for some part, different biological mechanisms may lead to insomnia in men and women, Prof. Posthuma said.

We also found a difference between men and women in terms of prevalence: in the sample we studied, including mainly people older than fifty years, 33% of the women reported to suffer from insomnia. For men this was 24%.

The teams findings were published today in the journal Nature Genetics.

_____

Anke R. Hammerschlag et al. Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits. Nature Genetics, published online June 12, 2017; doi: 10.1038/ng.3888

Read more:
Scientists Discover First Genes for Insomnia - Sci-News.com

B-Real, DNA Genetics and PRHBTD Media Announce Digital-First Reality Series, ‘Pimp My Grow’ – PR Newswire (press release)

LOS ANGELES, June 12, 2017 /PRNewswire/ --B-Real, DNA Genetics and PRHBTD Media,have joined forces to produce a new digital first reality series titled, "Pimp My Grow," aimed at cannabis enthusiasts.

DNA Genetics, one of the oldest and most respected genetics and grow experts in the Cannabis industry will visit Cannabis growers around the country and "Pimp Their Grows."Some growers may be new to the industry, looking to set-up their first personal grow for medical reasons, while others are building out industrial-sized indoor operations. All of them have one thing in common; they are looking to harness DNA's best-in-class expertise.

"We're psyched to meet with amateurs as well as experienced growers to help them grow the biggest, healthiest and most special plants!And we're going to bring along a few of our friends to help out," said DNA's Don/Aaron.

B-Real added, "I've seen a ton of good and bad growers and grows in this space. Nothing compares to the work that the DNA guys do.They will literally pimp out some grows.This is going to be unreal and unprecedented."

See more at http://www.prohbtd.com/pimpmygrow.

Drake Sutton-Shearer and Josh Otten from PRHBTD Media added, "Viewers will experience the thrill of growing with some of the best technology available. DNA and B-Real are experts in what they do, so it's a pleasure for us to help them show the world just what it takes to pimp out a grow."

The completed video series will result in seven episodes that showcase each grow operationand the hosts' expertise in helping each grower with their set-up.The series will initially be distributed across the PRHBTD MEDIA network to millions of viewers and then licensed for global content distribution.

B-Real and DNA Genetics will be working with some of their friends to provide product and service support when optimizing each grow. From lighting and nutrients to harvesting and storage, these world-class companies offer some of the best products and services on the market to ensure the highest quality plants and yield.

Added Greg Muller, CEO of leading LED lighting company Spectrum King: "We're excited to be a part of this series and work with these cannabis industry leaders to help show audiences how our technology can help increase potency yield and significant cost savings for growers."

Learn more atwww.prohbtd.com/pimpmygrow

About B-REAL

With his work in the pioneering hip-hop group Cypress Hill, rapper B-Real became something of a hip-hop legend for several reasons. Most immediately, his trademark rhyming style, featuring an exaggeratedly nasal whine and a jazz singer's skill at staying just behind DJ Muggs' already sluggish beats, was one of the most instantly recognizable flows of the 1990s. Furthermore, B-Real and his partners Sen Dog and DJ Muggs were the first Latino hip-hop stars, ushering in a richly varied sub-genre of hip-hop that thrives to this day. Finally, Cypress Hill's fervent proselytizing on the subject of marijuana legalization both brought the subject to its highest public awareness since the days of Cheech & Chong and paved the way for a generation of weed-happy middle-class high-school kids to discover and identify with hip-hop to an even greater degree than before.

About DNA Genetics

DNA Genetics, one of the most important seed companies in the world, has been at the forefront of the cannabis industry and culture for over a decade.DNA has won more than 150 awards worldwide at the most prestigious events and trade shows for their contributions to the cannabis industry, making it the most-awarded company in the world. DNA has won the illustrious High Times 'Top 10 Strain of the Year' award more than five times, is the only seed company to have received every award presented at the High Times Cannabis Cup events and was inducted into the High Times Seedbank Hall of Fame in 2009. Working with the medical and scientific community has been a priority, helping to provide alternative solutions to the current pharmaceutical approach. Collaborations with the Unconventional Foundation for Autism and Israeli Research are some of the examples. DNA Genetics is also very proud of their new partnership with Canadian Licensed Medical Producers, Tweed in Ontario, Canada. When working within the medical community, DNA Genetics is committed not only to effective medicine, but also to combining all beneficial parts of the plant for a better experience and more effective results for the patients.

About PRHBTD MEDIA

PRHBTD MEDIA provides world-class video production, digital marketing and branding solutions for more than 50 brand partners in the cannabis industry. As the leading content studio, PRHBTD also produces original video and editorial with multi-platform distribution across the PRHBTD Media Network, which includes prohbtd.com, AppleTV, Amazon Prime, Roku, Metacafe, Dailymotion and more, reaching 100+ million monthly consumers and business owners.

To learn more, contact whatsgood@prohbtd.com

Media Contact: handsonpr@aol.com

Related Images

image1.jpg

image2.png

image3.png

image4.png

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/b-real-dna-genetics-and-prohbtd-media-announce-digital-first-reality-series-pimp-my-grow-300472088.html

SOURCE PROHBTD

Read more from the original source:
B-Real, DNA Genetics and PRHBTD Media Announce Digital-First Reality Series, 'Pimp My Grow' - PR Newswire (press release)

I wasn’t sure about having a ‘test-tube baby’ – Chicago Tribune

When I first visited a fertility doctor because of pregnancy problems, I had no idea that the in vitro fertilization, or IVF, he was suggesting to help me was actually the "test-tube baby" technique that I'd heard about, an approach that had sounded scary, like something out of science fiction.

After I educated myself and started treatment, the concerns continued: Would the hormone-stimulating drugs have adverse effects on me? What would the drugs do to the fetus? And more important, would conceiving a child outside the womb (not actually in a test tube but in an embryology lab) have any long-term effects? Most important, would my child - if I would be lucky enough to give birth to one - be as physically and mentally healthy as naturally conceived children?

Articles and blogs fed into my worries - not to mention the online "mommy boards" at pregnancy and fertility websites where women trade rumors, innuendoes and fears, often based on nothing more than a friend's experience.

Since the first test-tube baby, Louise Brown, was born in England in 1978, about 6.5 million children have been born worldwide with the help of assisted reproductive technologies (ART) such as IVF. So there is now enough information to address my concerns. Overall, those findings leave me pretty confident that the risks are pretty small and well worth taking if, like me, you want to have a baby but can't.

Although taking fertility medications drove me crazy - some hormones gave me nightmares, others kept me up at night, and the main ones made my mind race loopily - looking at studies allowed me to conclude that IVF probably has no long-term bad effects.

For instance, a 2013 study of 21,646 women in Australia concluded that "there is no evidence of an increased risk of ovarian cancer following IVF in women who give birth." Another study of 9,825 American women found no link between gonadotropins - the drugs I was taking to increase my egg production - and ovarian cancer for women who gave birth. There was one worrisome point: Both studies found an increased cancer risk for women with "resistant infertility" - i.e., those who did not give birth - although the researchers did not know why.

A recent study in the journal JAMA of about 25,000 women who had fertility treatments between 1980 and 1995 found that those who had gone through IVF had no greater risk of getting breast cancer in the subsequent 21 years than those who used other techniques.

Whew. I went through nine rounds of IVF before I got pregnant, which means I took a lot of ovary-stimulating drugs, so these studies are reassuring.

"Numerous studies and opinions from [the American Society for Reproductive Medicine] confirm low risk for ovarian and breast cancer from the use of fertility drugs, regardless of the number of IVF cycles performed," said Jeffrey Braverman, founder and medical director at Braverman IVF & Reproductive Immunology in New York.

So how about risks to the baby? Would he or she be affected by her medically assisted conception?

Two studies have raised concerns.

A 2016 study in JAMA Pediatrics found increased risk for birth defects in babies conceived through ART. The study, which involved more than 4 million infants, found that "singleton infants conceived using ART were 40 percent more likely to have a nonchromosomal birth defect (such as cleft lip and/or palate or a congenital heart defect) compared with all other singleton births."

The researchers acknowledged that the study "did not account for some factors related to infertility that might explain the observed increases in risk for birth defects." In other words, IVF may not have caused the defects. They recommended further research.

A comprehensive review of a group of other studies suggested that the risk for developmental disabilities was greater with ART - which, in addition to IVF, includes egg freezing and surrogacy - than with natural childbirth. The review examined studies of IVF and autism, cerebral palsy, intellectual disability, attention-deficit/hyperactivity disorder and sensory impairment, among others, and found conflicting information, no correlation or that the disabilities could have been caused by other factors such as preterm birth.

And a study published in March found an increased risk of neoplasms - tumors that can be benign or malignant - in children born through ART.

But I focused on a study that followed children conceived with ART into their teenage years. It offers a much more reassuring view. The study, published in January, compared 253 16- and 17-year-olds who were conceived with fertility treatments to a cohort of teenagers conceived naturally and found that "no differences were detected in general and mental health of ART adolescents or cognitive ability, compared with the reference group." The researchers, who said this was the first long-term study of such children, concluded that their "preliminary results provide reassurance that in the long run, health and functioning of ART-conceived adolescents is not compromised."

One of the researchers on the study, Mark Weiser, a psychiatry professor at Tel Aviv University's Sackler School of Medicine, said in an interview that the findings should be a relief to parents who used IVF and other assisted reproductive technology. "We show there is nothing wrong with these kids" when compared with children born naturally. "This is a very positive message to parents who are not able to get pregnant on their own. If you look down the line, the kids are perfectly normal."

As for me: After an uneventful pregnancy, my daughter was born full term nearly two years ago at a healthy six pounds, six ounces, with all her fingers and toes and brown hair that would soon turn to curls. She is a delightful, chatty, feisty toddler. Every parent worries about their child, and I know that I will be no different. But for now it seems clear to me that the risks of having used IVF were minimal - and the reward huge.

Go here to read the rest:
I wasn't sure about having a 'test-tube baby' - Chicago Tribune